Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hu Liang

Showing results (151-160 of 215) with videos related to

Pageof 22
Sort By:
Hepatology (Baltimore, Md.)|October 20, 2012
Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinomaQiong-Zhu Dong, Xiao-Fei Zhang, Yue Zhao, et al.
Cell Death & Disease|January 14, 2022
Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblastsChong Zhang, Xiang-Yu Wang, Peng Zhang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 19, 2018
RA190, a Proteasome Subunit ADRM1 Inhibitor, Suppresses Intrahepatic Cholangiocarcinoma by Inducing NF-KB-Mediated Cell ApoptosisGuang-Yang Yu, Xuan Wang, Su-Su Zheng, et al.
Cancer Science|October 15, 2010
Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell lineGuo-Cai Li, Qing-Hai Ye, Yu-Hua Xue, et al.
Hepatology (Baltimore, Md.)|October 31, 2008
Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinomaBing-Sheng Sun, Qiong-Zhu Dong, Qing-Hai Ye, et al.
Cancer Science|January 12, 2011
Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinomaChun Dai, Qiong-Zhu Dong, Ning Ren, et al.
Theranostics|May 17, 2021
Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancerKai-Li Zhang, Wen-Wei Zhu, Sheng-Hao Wang, et al.
Clinical & Translational Immunology|July 4, 2025
The role of immunochemotherapy maintenance in metastatic nasopharyngeal carcinoma: insights from a cohort study in an endemic regionZhuoying Luo, Yue Xia, Yuping Zhao, et al.
Gastroenterology|February 5, 2013
Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomesAnuradha Budhu, Stephanie Roessler, Xuelian Zhao, et al.
BMC Cancer|September 6, 2007
Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinomaKe-Feng Lei, Yan-Fang Wang, Xiao-Qun Zhu, et al.
Pageof 22

Showing results (151-160 of 215) with videos related to

Sort By:
Pageof 22
Hepatology (Baltimore, Md.)|October 20, 2012
Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinomaQiong-Zhu Dong, Xiao-Fei Zhang, Yue Zhao, et al.
Cell Death & Disease|January 14, 2022
Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblastsChong Zhang, Xiang-Yu Wang, Peng Zhang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 19, 2018
RA190, a Proteasome Subunit ADRM1 Inhibitor, Suppresses Intrahepatic Cholangiocarcinoma by Inducing NF-KB-Mediated Cell ApoptosisGuang-Yang Yu, Xuan Wang, Su-Su Zheng, et al.
Cancer Science|October 15, 2010
Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell lineGuo-Cai Li, Qing-Hai Ye, Yu-Hua Xue, et al.
Hepatology (Baltimore, Md.)|October 31, 2008
Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinomaBing-Sheng Sun, Qiong-Zhu Dong, Qing-Hai Ye, et al.
Cancer Science|January 12, 2011
Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinomaChun Dai, Qiong-Zhu Dong, Ning Ren, et al.
Theranostics|May 17, 2021
Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancerKai-Li Zhang, Wen-Wei Zhu, Sheng-Hao Wang, et al.
Clinical & Translational Immunology|July 4, 2025
The role of immunochemotherapy maintenance in metastatic nasopharyngeal carcinoma: insights from a cohort study in an endemic regionZhuoying Luo, Yue Xia, Yuping Zhao, et al.
Gastroenterology|February 5, 2013
Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomesAnuradha Budhu, Stephanie Roessler, Xuelian Zhao, et al.
BMC Cancer|September 6, 2007
Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinomaKe-Feng Lei, Yan-Fang Wang, Xiao-Qun Zhu, et al.
Pageof 22